900 Participants Needed

An Innovative Master Platform for Clinical Trials in Mood Disorders

(ENABLE Trial)

Recruiting at 7 trial locations
SK
AS
Overseen ByAbbey Schlatman
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: St. Joseph's Healthcare Hamilton
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Mood disorders such as depression and bipolar disorder affect over 350 million people around the world. While several effective treatments exist, it is often difficult to match the right treatment to an individual person. Repeated efforts to find the right treatment contribute to poor functioning, low quality of life, and prolongs the time it takes to get well. Most areas of medicine are able to use 'biomarkers' or clinical tests, blood tests, or imaging to help diagnose and treat illness. The search for biomarkers in mood disorders is advancing, but one roadblock to progress is the lack of large, standardized studies of mood disorders that are needed to accurately identify biomarkers. The aim of the ENABLE platform is to provide the Canadian neuroscience community a standardized way of collecting biomarker data from individuals with a range of mood disorders symptoms. In addition, this 'master clinical trial platform' framework will provide a pool of participants who can be recruited into biomarker-based clinical trials.

Who Is on the Research Team?

BN

Benicio N Frey

Principal Investigator

St. Joseph's Healthcare Hamilton

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 16 years old or older.
I have been diagnosed with bipolar or depressive disorders according to DSM-5.
I am fluent in English and can complete interviews and questionnaires.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Tier 1 Assessment

Participants complete clinical assessments, including clinician-administered and self-report measures

Varies

Tier 2 Assessment

Participants provide blood samples, undergo neuroimaging procedures (MRI and EEG), and wear an actigraphy device for two weeks

2 weeks

Follow-up

Participants are monitored for safety and effectiveness after assessments

4 weeks

What Are the Treatments Tested in This Trial?

Find a Clinic Near You

Who Is Running the Clinical Trial?

St. Joseph's Healthcare Hamilton

Lead Sponsor

Trials
203
Recruited
26,900+

Simon Fraser University

Collaborator

Trials
59
Recruited
12,500+

University of British Columbia

Collaborator

Trials
1,506
Recruited
2,528,000+

Unity Health Toronto

Collaborator

Trials
572
Recruited
470,000+

Centre for Addiction and Mental Health

Collaborator

Trials
388
Recruited
84,200+

Queen's University

Collaborator

Trials
382
Recruited
122,000+

University of Ottawa

Collaborator

Trials
231
Recruited
267,000+

University of Calgary

Collaborator

Trials
827
Recruited
902,000+

McGill University

Collaborator

Trials
421
Recruited
1,017,000+

Nova Scotia Health Authority

Collaborator

Trials
302
Recruited
95,300+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity